Home

Douglas H. Shulman

CIK 1726926 · President & CEO · last filed 2026-05-15

Douglas H. Shulman is a President & CEO who has filed 67 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for CVS, was dated May 15, 2026. Across all open-market trades the lifetime net is −$14.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $17.0M across reported positions. 5 SEC filings were submitted jointly with Bank of New York Mellon Corp.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$16.96M

Companies

3

Total Filings

67

Lifetime Open-Market Net

-$14.52M

Filer Profile

Reported Address
C/O ONEMAIN HOLDINGS, INC.
601 N.W. SECOND STREET
EVANSVILLE, IN 47708
Related Filers
Bank of New York Mellon Corp — 5 joint filings, latest 2018-02-28
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CVS Director 5,929 $94.49 $560.2K $0 4 2026-05-15
OMF President & CEO 266,597 $61.53 $16.40M -$14.52M 48 2026-02-24
Bank of New York Mellon Corp (BK) Delisted Sr. Executive Vice President 48,648 $137.16 $6.67M $0 4 2018-02-28

Recent Filings

67 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-15 CVS Grant (A) — $0 EDGAR
2026-02-24 OMF Tax (F) −39,863 -$2.29M EDGAR
2026-02-13 OMF Grant (A) +77,724 $0 EDGAR
2026-01-16 OMF Mixed +43,206 -$4.55M EDGAR
2026-01-02 OMF Notice (144) −57,500 -$3.93M EDGAR
2026-01-02 OMF Sell (S) −57,500 -$3.93M EDGAR
2025-11-21 CVS Grant (A) +1,652 $125.6K EDGAR
2025-11-05 OMF Sell (S) −35,000 -$2.08M EDGAR
2025-11-03 OMF Notice (144) −35,000 -$2.08M EDGAR
2025-09-09 OMF Gift (G) −8,500 $0 EDGAR
Showing 1–10 of 67
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.